Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials

摘要

Fecal transplant is associated with reduction in the expression of antibiotic‐resistance genes in patients with decompensated cirrhosis. Genes focused on beta‐lactamase and vancomycin resistance reduced after fecal transplant regardless of pre‐procedure antibiotics and concurrent use of lactulose, rifaximin or PPIs.